蒂维克健康首席执行官强调Z-PAP呼吸器产品的增长和战略前景. Tivic Health CEO highlights growth in Z-PAP respiratory product and strategic outlook.

公司的首席执行官史蒂夫·塔利斯向股东发出了一封信,详细介绍了该公司的财务表现和战略前景. Tivic Health CEO Steve Tullis sent a letter to shareholders detailing the company's financial performance and strategic outlook. 他强调了他们呼吸系统健康产品Z-PAP的显著增长,并提到公司仍专注于扩大其市场存在. He highlighted significant growth in their respiratory health product, the Z-PAP, and mentioned that the company remains focused on expanding its market presence. 公司在竞争环境中走向前进的道路. The letter also addresses recent leadership changes and the company's path forward amidst a competitive landscape.